title: Arginine-based cationic liposomes for efficient in vitro plasmid DNA delivery with low cytotoxicity.
abstract: BACKGROUND
  Currently available gene delivery vehicles have many limitations such as low gene delivery efficiency and high cytotoxicity. To overcome these drawbacks, we designed and synthesized two cationic lipids comprised of n-tetradecyl alcohol as the hydrophobic moiety, 3-hydrocarbon chain as the spacer, and different counterions (eg, hydrogen chloride [HCl] salt or trifluoroacetic acid [TFA] salt) in the arginine head group.
  
  
  METHODS
  Cationic lipids were hydrated in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer to prepare cationic liposomes and characterized in terms of their size, zeta potential, phase transition temperature, and morphology. Lipoplexes were then prepared and characterized in terms of their size and zeta potential in the absence or presence of serum. The morphology of the lipoplexes was determined using transmission electron microscopy and atomic force microscopy. The gene delivery efficiency was evaluated in neuronal cells and HeLa cells and compared with that of lysine-based cationic assemblies and Lipofectamine™ 2000. The cytotoxicity level of the cationic lipids was investigated and compared with that of Lipofectamine™ 2000.
  
  
  RESULTS
  We synthesized arginine-based cationic lipids having different counterions (ie, HCl-salt or TFA-salt) that formed cationic liposomes of around 100 nm in size. In the absence of serum, lipoplexes prepared from the arginine-based cationic liposomes and plasmid (p) DNA formed large aggregates and attained a positive zeta potential. However, in the presence of serum, the lipoplexes were smaller in size and negative in zeta potential. The morphology of the lipoplexes was vesicular. Arginine-based cationic liposomes with HCl-salt showed the highest transfection efficiency in PC-12 cells. However, arginine-based cationic liposomes with TFA salt showed the highest transfection efficiency in HeLa cells, regardless of the presence of serum, with very low associated cytotoxicity.
  
  
  CONCLUSIONS
  The gene delivery efficiency of amino acid-based cationic assemblies is influenced by the amino acids (ie, arginine or lysine) present as the hydrophilic head group and their associated counterions.
authors: Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University (TWIns), Tokyo, Japan.
authors: Satya Ranjan
authors: SR
authors: Sarker
authors: Yumiko
authors: Y
authors: Aoshima
authors: Ryosuke
authors: R
authors: Hokama
authors: Takafumi
authors: T
authors: Inoue
authors: Keitaro
authors: K
authors: Sou
authors: Shinji
authors: S
authors: Takeoka
mesh_terms: D000818:Animals; D001120:Arginine / Q000737:chemistry*; D002412:Cations / Q000737:chemistry; D002470:Cell Survival / Q000187:drug effects; D004247:DNA / Q000008:administration & dosage* / Q000737:chemistry* / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D008081:Liposomes / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D016716:PC12 Cells; D010957:Plasmids / Q000008:administration & dosage* / Q000235:genetics; D051381:Rats; D014162:Transfection / Q000379:methods*
chemical_list: D002412:Cations; D008081:Liposomes; D004247:DNA; D001120:Arginine
keywords: cationic liposome; counterions; cytotoxicity; pDNA; transfection efficiency
references: Biochim Biophys Acta. 2009 May;1788(5):1148-58
references: 19249283
references: Bioconjug Chem. 2001 Nov-Dec;12(6):1005-11
references: 11716693
references: J Biol Chem. 2011 May 27;286(21):18982-93
references: 21471199
references: Biosci Rep. 2006 Aug;26(4):301-24
references: 17029003
references: Mol Ther. 2006 Sep;14(3):343-50
references: 16765648
references: Biochim Biophys Acta. 1999 Jan 8;1415(2):331-41
references: 9889391
references: Bioconjug Chem. 2010 May 19;21(5):988-93
references: 20433165
references: Nature. 2001 Dec 13;414(6865):677
references: 11742355
references: Bioconjug Chem. 2007 Nov-Dec;18(6):2144-58
references: 18030994
references: Br J Cancer. 1992 Nov;66(5):781-6
references: 1358166
references: Int J Pharm. 2012 Jan 17;422(1-2):364-73
references: 22079713
references: J Control Release. 2006 Nov 28;116(2):255-64
references: 16914222
references: Pflugers Arch. 2000 Apr;439(6):730-8
references: 10784347
references: Biomaterials. 2008 Aug;29(22):3269-77
references: 18456321
references: Bioconjug Chem. 2001 Jan-Feb;12(1):108-13
references: 11170373
references: Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11539-44
references: 16051701
references: Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7567-72
references: 10840060
references: J Med Chem. 2007 May 17;50(10):2432-42
references: 17444625
references: Nucleic Acids Res. 1999 Oct 1;27(19):3792-8
references: 10481017
references: Proc Natl Acad Sci U S A. 1987 Nov;84(21):7413-7
references: 2823261
references: J Gene Med. 2004 Apr;6(4):405-14
references: 15079815
references: Exp Neurol. 2002 Sep;177(1):75-87
references: 12429212
references: Biochim Biophys Acta. 1985 Jan 10;812(1):223-33
references: 3967013
references: J Biol Chem. 1994 Jan 28;269(4):2550-61
references: 8300583
references: J Am Chem Soc. 2007 Sep 19;129(37):11408-20
references: 17718562
references: J Membr Biol. 2002 Oct 1;189(3):167-79
references: 12395282
references: Biochim Biophys Acta. 1997 Oct 23;1329(2):345-56
references: 9371426
references: Nanomedicine. 2010 Feb;6(1):70-7
references: 19447207
references: Gene Ther. 1999 Apr;6(4):585-94
references: 10476218
references: Bioconjug Chem. 2006 Nov-Dec;17(6):1530-6
references: 17105233
references: Pharm Res. 2008 May;25(5):983-98
references: 17932730
references: Hum Gene Ther. 2004 Sep;15(9):896-905
references: 15353044
references: J Neurosci Methods. 2005 Mar 15;142(1):137-43
references: 15652627
references: Proc Natl Acad Sci U S A. 1989 Sep;86(18):6982-6
references: 2780554
references: J Med Chem. 2004 Apr 8;47(8):2123-32
references: 15056009
references: Biochim Biophys Acta. 2011 Jan;1808(1):341-51
references: 20937247
references: J Med Chem. 2008 Apr 24;51(8):2533-40
references: 18376817
references: J Gene Med. 2003 Sep;5(9):803-17
references: 12950071
references: Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9682-6
references: 8790391
references: J Control Release. 2007 Nov 20;123(3):184-94
references: 17913276
references: Mol Ther. 2011 Jun;19(6):1141-51
references: 21505423
references: Bioconjug Chem. 2008 Feb;19(2):418-20
references: 18186598
references: Nature. 1998 Apr 30;392(6679 Suppl):25-30
references: 9579858
references: J Med Chem. 2005 Feb 10;48(3):812-20
references: 15689165
references: Bioconjug Chem. 2008 May;19(5):1055-63
references: 18429628
references: Mol Membr Biol. 2003 Jan-Mar;20(1):35-43
references: 12745924
references: Brain Res Mol Brain Res. 2005 Oct 3;139(2):361-6
references: 16039006
references: Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):598-607
references: 18045727
references: Trends Biotechnol. 1997 Jun;15(6):217-24
references: 9183864
references: Bioconjug Chem. 2002 Mar-Apr;13(2):378-84
references: 11906277
references: Methods Enzymol. 2006;406:374-88
references: 16472671
references: Biophys J. 2004 Jul;87(1):609-14
references: 15240493
references: Hum Gene Ther. 1996 Oct 20;7(16):1947-54
references: 8930654
references: Biomacromolecules. 2011 Jul 11;12(7):2440-6
references: 21657799